[1]
Vashakidze, E. et al. 2021. TREATMENT WITH BARICITINIB INMODERATE AND SEVERE COVID-19 PATIENTS. Collection of Scientific Works of Tbilisi State Medical University. 55, (Feb. 2021), 69–70. DOI:https://doi.org/10.52340/csw.2021.55.01.